| Year |
Citation |
Score |
| 2022 |
Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, Haenisch F, Broek JA, Suarez-Pinilla P, Ruland T, Auyeung B, Mikova O, Kabacs N, Arolt V, Baron-Cohen S, ... ... Bahn S, et al. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Translational Psychiatry. 12: 457. PMID 36310155 DOI: 10.1038/s41398-022-02229-w |
0.341 |
|
| 2022 |
Lago SG, Tomasik J, van Rees GF, Rustogi N, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, Bahn S. Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia. Brain, Behavior, and Immunity. 103: 37-49. PMID 35381347 DOI: 10.1016/j.bbi.2022.03.016 |
0.312 |
|
| 2020 |
Lago SG, Tomasik J, van Rees GF, Rubey M, Gonzalez-Vioque E, Ramsey JM, Haenisch F, Broek JA, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, ... ... Bahn S, et al. Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior, and Immunity. PMID 32898636 DOI: 10.1016/J.Bbi.2020.07.043 |
0.443 |
|
| 2020 |
Han SYS, Tomasik J, Rustogi N, Lago SG, Barton-Owen G, Eljasz P, Cooper JD, Ozcan S, Olmert T, Farrag LP, Friend LV, Bell E, Cowell D, Thomas G, Tuytten R, ... Bahn S, et al. Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood. Brain, Behavior, and Immunity. PMID 32861718 DOI: 10.1016/J.Bbi.2020.08.011 |
0.332 |
|
| 2020 |
Olmert T, Cooper JD, Han SYS, Barton-Owen G, Farrag L, Bell E, Friend LV, Ozcan S, Rustogi N, Preece RL, Eljasz P, Tomasik J, Cowell D, Bahn S. A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study. Jmir Research Protocols. 9: e18453. PMID 32773373 DOI: 10.2196/18453 |
0.331 |
|
| 2020 |
Kittel-Schneider S, Hahn T, Haenisch F, McNeill R, Reif A, Bahn S. Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression. Frontiers in Psychiatry. 11: 189. PMID 32372978 DOI: 10.3389/Fpsyt.2020.00189 |
0.338 |
|
| 2020 |
Tomasik J, Rustogi N, Larsen JR, Jakobsen MI, Svensson CK, Vedtofte L, Jakobsen MSL, Jespersen HR, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Correll CU, Holst JJ, Vilsbøll T, ... Bahn S, et al. Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients Schizophrenia Bulletin Open. 1. DOI: 10.1093/schizbullopen/sgaa044 |
0.3 |
|
| 2019 |
Han SYS, Cooper JD, Ozcan S, Rustogi N, Penninx BWJH, Bahn S. Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals. Translational Psychiatry. 9: 277. PMID 31699963 DOI: 10.1038/S41398-019-0623-2 |
0.325 |
|
| 2019 |
Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Schizophrenia Bulletin. PMID 31504969 DOI: 10.1093/Schbul/Sbz068 |
0.307 |
|
| 2019 |
Çakici N, Bot M, Lamers F, Janssen T, van der Spek PJ, de Haan L, Bahn S, Penninx BWJH, van Beveren NJM. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31230885 DOI: 10.1016/J.Euroneuro.2019.05.010 |
0.423 |
|
| 2019 |
Lago SG, Tomasik J, van Rees GF, Steeb H, Cox DA, Rustogi N, Ramsey JM, Bishop JA, Petryshen T, Haggarty SJ, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, van Beveren NJ, ... Bahn S, et al. Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Science Advances. 5: eaau9093. PMID 31086815 DOI: 10.1126/Sciadv.Aau9093 |
0.35 |
|
| 2019 |
Tomasik J, Lago SG, Vázquez-Bourgon J, Papiol S, Suárez-Pinilla P, Crespo-Facorro B, Bahn S. Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. Jama Psychiatry. PMID 30942838 DOI: 10.1001/Jamapsychiatry.2019.0304 |
0.331 |
|
| 2019 |
Cooper JD, Han SYS, Tomasik J, Ozcan S, Rustogi N, van Beveren NJM, Leweke FM, Bahn S. Multimodel inference for biomarker development: an application to schizophrenia. Translational Psychiatry. 9: 83. PMID 30745560 DOI: 10.1038/S41398-019-0419-4 |
0.415 |
|
| 2018 |
Breen MS, Ozcan S, Ramsey JM, Wang Z, Ma'ayan A, Rustogi N, Gottschalk MG, Webster MJ, Weickert CS, Buxbaum JD, Bahn S. Temporal proteomic profiling of postnatal human cortical development. Translational Psychiatry. 8: 267. PMID 30518843 DOI: 10.1038/S41398-018-0306-4 |
0.331 |
|
| 2018 |
Lago SG, Tomasik J, van Rees GF, Ramsey JM, Haenisch F, Cooper JD, Broek JA, Suarez-Pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, Arolt V, Baron-Cohen S, Crespo-Facorro B, ... Bahn S, et al. Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks. Molecular Psychiatry. PMID 30038233 DOI: 10.1038/S41380-018-0123-4 |
0.395 |
|
| 2018 |
Lago S, Bahn S. Clinical trials and therapeutic rationale for drug repurposing in schizophrenia. Acs Chemical Neuroscience. PMID 29944339 DOI: 10.1021/Acschemneuro.8B00205 |
0.344 |
|
| 2018 |
Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophrenia Research. PMID 29478863 DOI: 10.1016/J.Schres.2018.02.012 |
0.373 |
|
| 2018 |
Preece RL, Han SYS, Bahn S. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders. Expert Review of Proteomics. PMID 29466886 DOI: 10.1080/14789450.2018.1444483 |
0.402 |
|
| 2018 |
Berger M, Juster RP, Westphal S, Amminger GP, Bogerts B, Schiltz K, Bahn S, Steiner J, Sarnyai Z. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology. 90: 35-42. PMID 29427955 DOI: 10.1016/J.Psyneuen.2018.02.001 |
0.618 |
|
| 2018 |
Gottschalk MG, Mortas P, Haman M, Ozcan S, Biemans B, Bahn S. Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 195-210. PMID 29174946 DOI: 10.1016/J.Euroneuro.2017.11.002 |
0.323 |
|
| 2017 |
Cooper JD, Ozcan S, Gardner RM, Rustogi N, Wicks S, van Rees GF, Leweke FM, Dalman C, Karlsson H, Bahn S. Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots. Translational Psychiatry. 7: 1290. PMID 29249827 DOI: 10.1038/S41398-017-0027-0 |
0.467 |
|
| 2017 |
van Rees GF, Lago SG, Cox DA, Tomasik J, Rustogi N, Weigelt K, Ozcan S, Cooper J, Drexhage H, Markus Leweke F, Bahn S. Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients. Brain, Behavior, and Immunity. PMID 28988033 DOI: 10.1016/J.Bbi.2017.10.003 |
0.397 |
|
| 2017 |
Chan MK, Cooper JD, Heilmann-Heimbach S, Frank J, Witt SH, Nöthen MM, Steiner J, Rietschel M, Bahn S. Associations between SNPs and immune-related circulating proteins in schizophrenia. Scientific Reports. 7: 12586. PMID 28974776 DOI: 10.1038/S41598-017-12986-0 |
0.4 |
|
| 2017 |
Wesseling H, Elgersma Y, Bahn S. A brain proteomic investigation of rapamycin effects in the Tsc1(+/-) mouse model. Molecular Autism. 8: 41. PMID 28775826 DOI: 10.1186/S13229-017-0151-Y |
0.323 |
|
| 2017 |
Kannan G, Gressitt KL, Yang S, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Bahn S, Leweke FM, Dickerson FB, Yolken RH, et al. Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Translational Psychiatry. 7: e1186. PMID 28763062 DOI: 10.1038/Tp.2017.162 |
0.398 |
|
| 2017 |
Ozcan S, Cooper JD, Lago SG, Kenny D, Rustogi N, Stocki P, Bahn S. Towards reproducible MRM based biomarker discovery using dried blood spots. Scientific Reports. 7: 45178. PMID 28345601 DOI: 10.1038/Srep45178 |
0.335 |
|
| 2017 |
Crabtree GW, Sun Z, Kvajo M, Broek JA, Fénelon K, McKellar H, Xiao L, Xu B, Bahn S, O'Donnell JM, Gogos JA. Alteration of neuronal excitability and short-term synaptic plasticity in the prefrontal cortex of a mouse model of mental illness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28283561 DOI: 10.1523/Jneurosci.4345-15.2017 |
0.354 |
|
| 2017 |
Breen MS, Uhlmann A, Ozcan S, Chan M, Pinto D, Bahn S, Stein DJ. Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis. Scientific Reports. 7: 43777. PMID 28252112 DOI: 10.1038/Srep43777 |
0.339 |
|
| 2017 |
Gottschalk MG, Leussis MP, Ruland T, Gjeluci K, Petryshen TL, Bahn S. Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruption. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28109561 DOI: 10.1016/J.Euroneuro.2017.01.001 |
0.351 |
|
| 2017 |
Cox D, Gottschalk M, Wesseling H, Ernst A, Cooper J, Bahn S. A novel methodology to evaluate the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology European Psychiatry. 41: s807-s807. DOI: 10.1016/J.Eurpsy.2017.01.1563 |
0.427 |
|
| 2016 |
Jordan W, Dobrowolny H, Bahn S, Bernstein HG, Brigadski T, Frodl T, Isermann B, Lessmann V, Pilz J, Rodenbeck A, Schiltz K, Schwedhelm E, Tumani H, Wiltfang J, Guest PC, et al. Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders. European Archives of Psychiatry and Clinical Neuroscience. PMID 27913877 DOI: 10.1007/S00406-016-0749-7 |
0.412 |
|
| 2016 |
Cox DA, Gottschalk MG, Stelzhammer V, Wesseling H, Cooper JD, Bahn S. Evaluation of molecular brain changes associated with environmental stress in rodent models compared to human major depressive disorder: a proteomic systems approach. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-31. PMID 27784204 DOI: 10.1080/15622975.2016.1252465 |
0.346 |
|
| 2016 |
Chan MK, Cooper JD, Bot M, Birkenhager TK, Bergink V, Drexhage HA, Steiner J, Rothermundt M, Penninx BW, Bahn S. Blood-based immune-endocrine biomarkers of treatment response in depression. Journal of Psychiatric Research. 83: 249-259. PMID 27693950 DOI: 10.1016/J.Jpsychires.2016.08.020 |
0.329 |
|
| 2016 |
Knöchel C, Kniep J, Cooper JD, Stäblein M, Wenzler S, Sarlon J, Prvulovic D, Linden DE, Bahn S, Stocki P, Ozcan S, Alves G, Carvalho AF, Reif A, Oertel-Knöchel V. Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. PMID 27549216 DOI: 10.1007/S00406-016-0724-3 |
0.427 |
|
| 2016 |
Lamers F, Bot M, Jansen R, Chan MK, Cooper JD, Bahn S, Penninx BW. Serum proteomic profiles of depressive subtypes. Translational Psychiatry. 6: e851. PMID 27404283 DOI: 10.1038/Tp.2016.115 |
0.316 |
|
| 2016 |
Cox DA, Gottschalk MG, Wesseling H, Ernst A, Cooper JD, Bahn S. Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology. Schizophrenia Research. PMID 27335180 DOI: 10.1016/J.Schres.2016.06.012 |
0.468 |
|
| 2016 |
Ramsey JM, Cooper JD, Bot M, Guest PC, Lamers F, Weickert CS, Penninx BW, Bahn S. Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA). Plos One. 11: e0156624. PMID 27232630 DOI: 10.1371/Journal.Pone.0156624 |
0.34 |
|
| 2016 |
Wesseling H, Xu B, Want EJ, Holmes E, Guest PC, Karayiorgou M, Gogos JA, Bahn S. System-based proteomic and metabonomic analysis of the Df(16)A(+/-) mouse identifies potential miR-185 targets and molecular pathway alterations. Molecular Psychiatry. PMID 27001617 DOI: 10.1038/Mp.2016.27 |
0.39 |
|
| 2015 |
Gottschalk MG, Cooper JD, Chan MK, Bot M, Penninx BW, Bahn S. Serum biomarkers predictive of depressive episodes in panic disorder. Journal of Psychiatric Research. 73: 53-62. PMID 26687614 DOI: 10.1016/J.Jpsychires.2015.11.012 |
0.32 |
|
| 2015 |
Chan MK, Cooper JD, Bot M, Steiner J, Penninx BW, Bahn S. Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach. Neuroendocrinology. PMID 26580065 DOI: 10.1159/000442208 |
0.312 |
|
| 2015 |
Chan MK, Cooper JD, Bahn S. Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles. Trends in Biotechnology. PMID 26549771 DOI: 10.1016/J.Tibtech.2015.09.010 |
0.307 |
|
| 2015 |
Tomasik J, Schwarz E, Lago SG, Rothermundt M, Leweke FM, van Beveren NJ, Guest PC, Rahmoune H, Steiner J, Bahn S. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain, Behavior, and Immunity. PMID 26541453 DOI: 10.1016/J.Bbi.2015.10.019 |
0.387 |
|
| 2015 |
Haenisch F, Cooper JD, Reif A, Kittel-Schneider S, Steiner J, Markus Leweke F, Rothermundt M, van Beveren NJ, Crespo-Facorro B, Niebuhr DW, Cowan DN, Weber NS, Yolken RH, Penninx BW, Bahn S. Towards a blood-based diagnostic panel for bipolar disorder. Brain, Behavior, and Immunity. PMID 26441135 DOI: 10.1016/J.Bbi.2015.10.001 |
0.333 |
|
| 2015 |
Tomasik J, Schultz TL, Kluge W, Yolken RH, Bahn S, Carruthers VB. Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia. Schizophrenia Bulletin. PMID 26392628 DOI: 10.1093/Schbul/Sbv134 |
0.418 |
|
| 2015 |
Dickerson F, Schroeder J, Stallings C, Origoni A, Bahn S, Yolken R. Multianalyte markers of schizophrenia and bipolar disorder: A preliminary study. Schizophrenia Research. 168: 450-5. PMID 26298538 DOI: 10.1016/J.Schres.2015.08.003 |
0.442 |
|
| 2015 |
Chan MK, Krebs MO, Cox D, Guest PC, Yolken RH, Rahmoune H, Rothermundt M, Steiner J, Leweke FM, van Beveren NJ, Niebuhr DW, Weber NS, Cowan DN, Suarez-Pinilla P, Crespo-Facorro B, ... ... Bahn S, et al. Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Translational Psychiatry. 5: e601. PMID 26171982 DOI: 10.1038/Tp.2015.91 |
0.437 |
|
| 2015 |
Bot M, Chan MK, Jansen R, Lamers F, Vogelzangs N, Steiner J, Leweke FM, Rothermundt M, Cooper J, Bahn S, Penninx BW. Serum proteomic profiling of major depressive disorder. Translational Psychiatry. 5: e599. PMID 26171980 DOI: 10.1038/Tp.2015.88 |
0.355 |
|
| 2015 |
Haenisch F, Alsaif M, Guest PC, Rahmoune H, Yolken RH, Dickerson F, Bahn S. Multiplex immunoassay analysis of plasma shows differences in biomarkers related to manic or mixed mood states in bipolar disorder patients. Journal of Affective Disorders. 185: 12-6. PMID 26142689 DOI: 10.1016/J.Jad.2015.05.065 |
0.355 |
|
| 2015 |
Tomasik J, Yolken RH, Bahn S, Dickerson FB. Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial. Biomarker Insights. 10: 47-54. PMID 26052224 DOI: 10.4137/Bmi.S22007 |
0.415 |
|
| 2015 |
Wesseling H, Want EJ, Guest PC, Rahmoune H, Holmes E, Bahn S. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model. Journal of Proteome Research. 14: 3174-87. PMID 26043028 DOI: 10.1021/Acs.Jproteome.5B00105 |
0.459 |
|
| 2015 |
Gottschalk MG, Cooper JD, Chan MK, Bot M, Penninx BW, Bahn S. Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder. Brain, Behavior, and Immunity. 48: 123-31. PMID 25929723 DOI: 10.1016/J.Bbi.2015.04.011 |
0.32 |
|
| 2015 |
Cox D, Chan MK, Bahn S. The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia. The Journal of Nervous and Mental Disease. 203: 393-9. PMID 25919386 DOI: 10.1097/Nmd.0000000000000289 |
0.429 |
|
| 2015 |
Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, Möller HJ, Dean B. Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 25899066 DOI: 10.1093/Ijnp/Pyv042 |
0.584 |
|
| 2015 |
Jaros JA, Rahmoune H, Wesseling H, Leweke FM, Ozcan S, Guest PC, Bahn S. Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia. Proteomics. Clinical Applications. 9: 907-16. PMID 25821032 DOI: 10.1002/Prca.201400148 |
0.431 |
|
| 2015 |
Bahn S, Chan MK. What can we learn about depression from gene expression in peripheral tissues? Biological Psychiatry. 77: 207-9. PMID 25542515 DOI: 10.1016/J.Biopsych.2014.10.019 |
0.406 |
|
| 2015 |
Stelzhammer V, Alsaif M, Chan MK, Rahmoune H, Steeb H, Guest PC, Bahn S. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients. Journal of Psychiatric Research. 60: 40-8. PMID 25455508 DOI: 10.1016/J.Jpsychires.2014.09.022 |
0.412 |
|
| 2015 |
Wesseling H, Rahmoune H, Tricklebank M, Guest PC, Bahn S. A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat brain. Journal of Proteome Research. 14: 411-21. PMID 25363195 DOI: 10.1021/Pr5009493 |
0.408 |
|
| 2015 |
Schwarz E, Steiner J, Guest PC, Bogerts B, Bahn S. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 22-30. PMID 24001020 DOI: 10.3109/15622975.2013.817685 |
0.372 |
|
| 2015 |
Broek JA, Lin Z, Van't Spijker H, Ozcan S, De Gruiter H, Haasdijk E, Willemsen R, De Zeeuw C, Bahn S. Proteomics investigation identifies prominent changes in synapse-related proteins in a fragile X mouse model Bmc Neuroscience. 16. DOI: 10.1186/1471-2202-16-S1-P21 |
0.363 |
|
| 2015 |
Stelzhammer V, Ozcan S, Gottschalk MG, Steeb H, Hodes GE, Guest PC, Rahmoune H, Wong EHF, Russo SJ, Bahn S. Central and peripheral changes underlying susceptibility and resistance to social defeat stress - A proteomic profiling study Diagnostics in Neuropsychiatry. 1: 1-7. DOI: 10.1016/J.Dineu.2015.08.001 |
0.341 |
|
| 2014 |
Gottschalk MG, Wesseling H, Guest PC, Bahn S. Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25609598 DOI: 10.1093/Ijnp/Pyu019 |
0.442 |
|
| 2014 |
Wesseling H, Gottschalk MG, Bahn S. Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25539505 DOI: 10.1093/Ijnp/Pyu015 |
0.478 |
|
| 2014 |
Chan MK, Gottschalk MG, Haenisch F, Tomasik J, Ruland T, Rahmoune H, Guest PC, Bahn S. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Progress in Neurobiology. 122: 45-72. PMID 25173695 DOI: 10.1016/J.Pneurobio.2014.08.002 |
0.429 |
|
| 2014 |
van Beveren NJ, Schwarz E, Noll R, Guest PC, Meijer C, de Haan L, Bahn S. Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Translational Psychiatry. 4: e430. PMID 25158005 DOI: 10.1038/Tp.2014.52 |
0.42 |
|
| 2014 |
Agarwal A, Zhang M, Trembak-Duff I, Unterbarnscheidt T, Radyushkin K, Dibaj P, Martins de Souza D, Boretius S, Brzózka MM, Steffens H, Berning S, Teng Z, Gummert MN, Tantra M, Guest PC, ... ... Bahn S, et al. Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. Cell Reports. 8: 1130-45. PMID 25131210 DOI: 10.1016/J.Celrep.2014.07.026 |
0.33 |
|
| 2014 |
Broek JA, Guest PC, Rahmoune H, Bahn S. Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins. Molecular Autism. 5: 41. PMID 25126406 DOI: 10.1186/2040-2392-5-41 |
0.372 |
|
| 2014 |
Tomasik J, Rahmoune H, Guest PC, Bahn S. Neuroimmune biomarkers in schizophrenia. Schizophrenia Research. PMID 25124519 DOI: 10.1016/J.Schres.2014.07.025 |
0.446 |
|
| 2014 |
Wesseling H, Guest PC, Lee CM, Wong EH, Rahmoune H, Bahn S. Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders. Molecular Autism. 5: 38. PMID 25061506 DOI: 10.1186/2040-2392-5-38 |
0.46 |
|
| 2014 |
Stelzhammer V, Haenisch F, Chan MK, Cooper JD, Steiner J, Steeb H, Martins-de-Souza D, Rahmoune H, Guest PC, Bahn S. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1599-608. PMID 24901538 DOI: 10.1017/S1461145714000819 |
0.606 |
|
| 2014 |
de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005 |
0.364 |
|
| 2014 |
Wesseling H, Guest PC, Lago SG, Bahn S. Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1327-41. PMID 24524332 DOI: 10.1017/S146114571400008X |
0.436 |
|
| 2014 |
Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, Ingudomnukul E, Auyeung B, Ruta L, Baron-Cohen S, Bahn S. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Molecular Autism. 5: 4. PMID 24467795 DOI: 10.1186/2040-2392-5-4 |
0.308 |
|
| 2014 |
Haenisch F, Alsaif M, Guest PC, Rahmoune H, Dickerson F, Yolken R, Bahn S. Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3β signaling in bipolar patients. Journal of Affective Disorders. 156: 139-43. PMID 24411062 DOI: 10.1016/J.Jad.2013.12.008 |
0.367 |
|
| 2014 |
Guest PC, Chan MK, Gottschalk MG, Bahn S. The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients. Biomarkers in Medicine. 8: 15-27. PMID 24325222 DOI: 10.2217/Bmm.13.83 |
0.454 |
|
| 2014 |
Broek JA, Brombacher E, Stelzhammer V, Guest PC, Rahmoune H, Bahn S. The need for a comprehensive molecular characterization of autism spectrum disorders. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 651-73. PMID 24229490 DOI: 10.1017/S146114571300117X |
0.354 |
|
| 2014 |
Schwarz E, van Beveren NJ, Ramsey J, Leweke FM, Rothermundt M, Bogerts B, Steiner J, Guest PC, Bahn S. Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophrenia Bulletin. 40: 787-95. PMID 23934781 DOI: 10.1093/Schbul/Sbt105 |
0.447 |
|
| 2014 |
Herberth M, Rahmoune H, Schwarz E, Koethe D, Harris LW, Kranaster L, Witt SH, Spain M, Barnes A, Schmolz M, Leweke MF, Guest PC, Bahn S. Identification of a molecular profile associated with immune status in first-onset schizophrenia patients. Clinical Schizophrenia & Related Psychoses. 7: 207-15. PMID 23395839 DOI: 10.3371/Csrp.Hera.020113 |
0.423 |
|
| 2014 |
Ramsey J, Bahn S. P.8.b.023 Overlapping and distinct sex-specific serum molecular profiles in schizophrenia, depression, bipolar disorder, and Asperger syndrome European Neuropsychopharmacology. 24: S746-S747. DOI: 10.1016/S0924-977X(14)71204-0 |
0.408 |
|
| 2014 |
Ramsey J, Schwarz E, Guest P, Van Beveren N, Leweke M, Rothermundt M, Bogerts B, Steiner J, Bahn S. EPA-1234 – Distinct molecular phenotypes in male and female schizophrenia patients European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78476-7 |
0.431 |
|
| 2014 |
Bahn S. SERUM BIOMARKERS FOR PSYCHIATRIC DISORDERS Schizophrenia Research. 153: S16. DOI: 10.1016/S0920-9964(14)70049-0 |
0.333 |
|
| 2014 |
Sommer I, Bahn S, Shannon-Weickert C. THE LONG SEARCH FOR AN INFLAMMATORY COMPONENT IN SCHIZOPHRENIA Schizophrenia Research. 153: S15. DOI: 10.1016/S0920-9964(14)70047-7 |
0.353 |
|
| 2013 |
Ramsey JM, Schwarz E, Guest PC, van Beveren NJ, Leweke FM, Rothermundt M, Bogerts B, Steiner J, Bahn S. Distinct molecular phenotypes in male and female schizophrenia patients. Plos One. 8: e78729. PMID 24244349 DOI: 10.1371/Journal.Pone.0078729 |
0.436 |
|
| 2013 |
Koutroukides TA, Jaros JA, Amess B, Martins-de-Souza D, Guest PC, Rahmoune H, Levin Y, Deery M, Charles PD, Hester S, Groen A, Christoforou A, Howard J, Bond N, Bahn S, et al. Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 1061: 291-307. PMID 23963945 DOI: 10.1007/978-1-62703-589-7_18 |
0.582 |
|
| 2013 |
Wesseling H, Chan MK, Tsang TM, Ernst A, Peters F, Guest PC, Holmes E, Bahn S. A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2532-44. PMID 23942359 DOI: 10.1038/Npp.2013.160 |
0.428 |
|
| 2013 |
Ramsey JM, Guest PC, Broek JA, Glennon JC, Rommelse N, Franke B, Rahmoune H, Buitelaar JK, Bahn S. Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders. Molecular Autism. 4: 27. PMID 23915542 DOI: 10.1186/2040-2392-4-27 |
0.338 |
|
| 2013 |
Ernst A, Sharma AN, Elased KM, Guest PC, Rahmoune H, Bahn S. Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders. Translational Psychiatry. 3: e263. PMID 23715298 DOI: 10.1038/Tp.2013.42 |
0.376 |
|
| 2013 |
Gottschalk MG, Schwarz E, Bahn S. [Biomarker research in neuropsychiatry: challenges and potential]. Fortschritte Der Neurologie-Psychiatrie. 81: 243-9. PMID 23695789 DOI: 10.1055/S-0033-1335235 |
0.385 |
|
| 2013 |
Jaros JA, Guest PC, Bahn S, Martins-de-Souza D. Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis. Methods in Molecular Biology (Clifton, N.J.). 1002: 1-11. PMID 23625390 DOI: 10.1007/978-1-62703-360-2_1 |
0.554 |
|
| 2013 |
Guest PC, Martins-de-Souza D, Schwarz E, Rahmoune H, Alsaif M, Tomasik J, Turck CW, Bahn S. Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Medicine. 5: 25. PMID 23531373 DOI: 10.1186/Gm429 |
0.719 |
|
| 2013 |
Guest PC, Gottschalk MG, Bahn S. Proteomics: improving biomarker translation to modern medicine? Genome Medicine. 5: 17. PMID 23445684 DOI: 10.1186/Gm421 |
0.357 |
|
| 2013 |
Alsaif M, Haenisch F, Guest PC, Rahmoune H, Bahn S. Challenges in drug target discovery in bipolar disorder. Expert Opinion On Therapeutic Targets. 17: 565-77. PMID 23419165 DOI: 10.1517/14728222.2013.771169 |
0.356 |
|
| 2013 |
Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1199-207. PMID 23183131 DOI: 10.1016/J.Euroneuro.2012.10.012 |
0.351 |
|
| 2013 |
Harris LW, Guest PC, Wayland MT, Umrania Y, Krishnamurthy D, Rahmoune H, Bahn S. Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology. 38: 752-66. PMID 23084727 DOI: 10.1016/J.Psyneuen.2012.09.009 |
0.436 |
|
| 2013 |
Krishnamurthy D, Harris LW, Levin Y, Koutroukides TA, Rahmoune H, Pietsch S, Vanattou-Saifoudine N, Leweke FM, Guest PC, Bahn S. Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 478-89. PMID 22248022 DOI: 10.3109/15622975.2011.601759 |
0.454 |
|
| 2013 |
Gottschalk MG, Sarnyai Z, Guest PC, Harris LW, Bahn S. Translational neuropsychiatry of genetic and neurodevelopmental animal models of schizophrenia | Estudos traducionais de neuropsiquiatria e esquizofrenia: Modelos animais genéticos e de neurodesenvolvimento Revista De Psiquiatria Clinica. 40: 41-50. DOI: 10.1590/S0101-60832012005000007 |
0.647 |
|
| 2013 |
Rahmoune H, Harris LW, Guest PC, Bahn S. Targeting the inflammatory component of schizophrenia | Explorando o componente inflamatório da esquizofrenia Revista De Psiquiatria Clinica. 40: 28-34. DOI: 10.1590/S0101-60832012005000003 |
0.404 |
|
| 2013 |
Guest FL, Martins-de-Souza D, Rahmoune H, Bahn S, Guest PC. The effects of stress on hypothalamic-pituitary-adrenal (HPA) axis function in subjects with schizophrenia | Os efeitos do estresse na função do eixo hipotalâmico-pituitário-adrenal em indivíduos com esquizofrenia Revista De Psiquiatria Clinica. 40: 20-27. DOI: 10.1590/S0101-60832012005000002 |
0.63 |
|
| 2013 |
Bahn S, Schwarz E, Harris LW, Martins-de-Souza D, Rahmoune H, Guest PC. Biomarker blood tests for diagnosis and management of mental disorders: Focus on schizophrenia | Testes sanguíneos de biomarcadores para diagnóstico e tratamento de desordens mentais: Foco em esquizofrenia Revista De Psiquiatria Clinica. 40: 2-9. |
0.536 |
|
| 2012 |
Harris LW, Pietsch S, Cheng TM, Schwarz E, Guest PC, Bahn S. Comparison of peripheral and central schizophrenia biomarker profiles. Plos One. 7: e46368. PMID 23118852 DOI: 10.1371/Journal.Pone.0046368 |
0.457 |
|
| 2012 |
Guest PC, Urday S, Ma D, Stelzhammer V, Harris LW, Amess B, Pietsch S, Oheim C, Ozanne SE, Bahn S. Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission. Proteomics. 12: 3580-9. PMID 23071080 DOI: 10.1002/Pmic.201200376 |
0.446 |
|
| 2012 |
Stelzhammer V, Amess B, Martins-de-Souza D, Levin Y, Ozanne SE, Martin-Gronert MS, Urday S, Bahn S, Guest PC. Analysis of the rat hypothalamus proteome by data-independent label-free LC-MS/MS. Proteomics. 12: 3386-92. PMID 22997143 DOI: 10.1002/Pmic.201100642 |
0.551 |
|
| 2012 |
Tomasik J, Schwarz E, Guest PC, Bahn S. Blood test for schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 262: S79-83. PMID 22923188 DOI: 10.1007/S00406-012-0354-3 |
0.451 |
|
| 2012 |
Martins-de-Souza D, Guest PC, Harris LW, Vanattou-Saifoudine N, Webster MJ, Rahmoune H, Bahn S. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Translational Psychiatry. 2: e87. PMID 22832852 DOI: 10.1038/Tp.2012.13 |
0.629 |
|
| 2012 |
Schwarz E, Guest PC, Steiner J, Bogerts B, Bahn S. Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Translational Psychiatry. 2: e82. PMID 22832819 DOI: 10.1038/Tp.2012.3 |
0.42 |
|
| 2012 |
Alsaif M, Guest PC, Schwarz E, Reif A, Kittel-Schneider S, Spain M, Rahmoune H, Bahn S. Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection. Proteomics. Clinical Applications. 6: 297-303. PMID 22641612 DOI: 10.1002/Prca.201100061 |
0.355 |
|
| 2012 |
Jaros JA, Martins-de-Souza D, Rahmoune H, Rothermundt M, Leweke FM, Guest PC, Bahn S. Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls. Journal of Proteomics. 76: 43-55. PMID 22641159 DOI: 10.1016/J.Jprot.2012.05.027 |
0.644 |
|
| 2012 |
Ernst A, Ma D, Garcia-Perez I, Tsang TM, Kluge W, Schwarz E, Guest PC, Holmes E, Sarnyai Z, Bahn S. Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission. Journal of Proteome Research. 11: 3704-14. PMID 22613019 DOI: 10.1021/Pr300197D |
0.669 |
|
| 2012 |
Telford JE, Bones J, McManus C, Saldova R, Manning G, Doherty M, Leweke FM, Rothermundt M, Guest PC, Rahmoune H, Bahn S, Rudd PM. Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteins. Journal of Proteome Research. 11: 3743-52. PMID 22594947 DOI: 10.1021/Pr300218H |
0.429 |
|
| 2012 |
Martins-de-Souza D, Alsaif M, Ernst A, Harris LW, Aerts N, Lenaerts I, Peeters PJ, Amess B, Rahmoune H, Bahn S, Guest PC. The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia. Bmc Research Notes. 5: 146. PMID 22420779 DOI: 10.1186/1756-0500-5-146 |
0.628 |
|
| 2012 |
Jaros JA, Guest PC, Ramoune H, Rothermundt M, Leweke FM, Martins-de-Souza D, Bahn S. Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry. Journal of Proteomics. 76: 36-42. PMID 22382090 DOI: 10.1016/J.Jprot.2012.02.015 |
0.57 |
|
| 2012 |
Martins-de-Souza D, Guest PC, Mann DM, Roeber S, Rahmoune H, Bauder C, Kretzschmar H, Volk B, Baborie A, Bahn S. Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. Journal of Proteome Research. 11: 2533-43. PMID 22360420 DOI: 10.1021/Pr2012279 |
0.6 |
|
| 2012 |
Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Rahmoune H, Bahn S. Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. European Archives of Psychiatry and Clinical Neuroscience. 262: 657-66. PMID 22350622 DOI: 10.1007/S00406-012-0301-3 |
0.604 |
|
| 2012 |
Martins-de-Souza D, Guest PC, Rahmoune H, Bahn S. Proteomic approaches to unravel the complexity of schizophrenia. Expert Review of Proteomics. 9: 97-108. PMID 22292827 DOI: 10.1586/Epr.11.70 |
0.649 |
|
| 2012 |
Filiou MD, Martins-de-Souza D, Guest PC, Bahn S, Turck CW. To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics. 12: 736-47. PMID 22247077 DOI: 10.1002/Pmic.201100350 |
0.65 |
|
| 2012 |
Jaros JA, Martins-de-Souza D, Rahmoune H, Schwarz E, Leweke FM, Guest PC, Bahn S. Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience. 262: 453-5. PMID 22169887 DOI: 10.1007/S00406-011-0283-6 |
0.606 |
|
| 2012 |
Martins-de-Souza D, Guest PC, Guest FL, Bauder C, Rahmoune H, Pietsch S, Roeber S, Kretzschmar H, Mann D, Baborie A, Bahn S. Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analyses. Proteomics. 12: 500-4. PMID 22162416 DOI: 10.1002/Pmic.201100476 |
0.597 |
|
| 2012 |
Hradetzky E, Sanderson TM, Tsang TM, Sherwood JL, Fitzjohn SM, Lakics V, Malik N, Schoeffmann S, O'Neill MJ, Cheng TM, Harris LW, Rahmoune H, Guest PC, Sher E, Collingridge GL, ... ... Bahn S, et al. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 364-77. PMID 21956444 DOI: 10.1038/Npp.2011.219 |
0.416 |
|
| 2012 |
Schwarz E, Guest PC, Rahmoune H, Martins-de-Souza D, Niebuhr DW, Weber NS, Cowan DN, Yolken RH, Spain M, Barnes A, Bahn S. Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 627-32. PMID 21936765 DOI: 10.3109/15622975.2011.599861 |
0.641 |
|
| 2012 |
Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, ... ... Bahn S, et al. Identification of a biological signature for schizophrenia in serum. Molecular Psychiatry. 17: 494-502. PMID 21483431 DOI: 10.1038/Mp.2011.42 |
0.435 |
|
| 2012 |
Bahn S, Schwarz E, Harris LW, Martins-de-Souza D, Rahmoune H, Guest PC. Testes sanguíneos de biomarcadores para diagnóstico e tratamento de desordens mentais: foco em esquizofrenia Archives of Clinical Psychiatry (SãO Paulo). 40: 02-09. DOI: 10.1590/S0101-60832012005000005 |
0.471 |
|
| 2012 |
Bahn S, Alsaif M, Rahmoune H. S.06.01 Multi-omics profiling approaches to biomarker discovery in bipolar disorder European Neuropsychopharmacology. 22: S120. DOI: 10.1016/S0924-977X(12)70133-5 |
0.465 |
|
| 2012 |
Cotel M, Hradetzky E, Bahn S, Tricklebank M, O'Neill MJ. Poster #13 EXPRESSION AND DISTRIBUTION PROFILES OF GLUTAMATERGIC RECEPTORS IN THE MAME17 NEURODEVELOPMENTAL RAT MODEL OF SCHIZOPHRENIA Schizophrenia Research. 136: S95-S96. DOI: 10.1016/S0920-9964(12)70329-8 |
0.365 |
|
| 2012 |
Bahn S. DISEASE BIOMARKERS FOR SCHIZOPHRENIA – FROM LABORATORY TO PATIENT BEDSIDE Schizophrenia Research. 136: S54. DOI: 10.1016/S0920-9964(12)70195-0 |
0.405 |
|
| 2011 |
Bahn S, Noll R, Barnes A, Schwarz E, Guest PC. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market. International Review of Neurobiology. 101: 299-327. PMID 22050857 DOI: 10.1016/B978-0-12-387718-5.00012-2 |
0.416 |
|
| 2011 |
Izmailov R, Guest PC, Bahn S, Schwarz E. Algorithm development for diagnostic biomarker assays. International Review of Neurobiology. 101: 279-98. PMID 22050856 DOI: 10.1016/B978-0-12-387718-5.00011-0 |
0.371 |
|
| 2011 |
Schwarz E, VanBeveren NJ, Guest PC, Izmailov R, Bahn S. The application of multiplexed assay systems for molecular diagnostics. International Review of Neurobiology. 101: 259-78. PMID 22050855 DOI: 10.1016/B978-0-12-387718-5.00010-9 |
0.415 |
|
| 2011 |
Sarnyai Z, Alsaif M, Bahn S, Ernst A, Guest PC, Hradetzky E, Kluge W, Stelzhammer V, Wesseling H. Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders. International Review of Neurobiology. 101: 203-38. PMID 22050853 DOI: 10.1016/B978-0-12-387718-5.00008-0 |
0.632 |
|
| 2011 |
Guest PC, Martins-de-Souza D, Vanattou-Saifoudine N, Harris LW, Bahn S. Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia. International Review of Neurobiology. 101: 145-68. PMID 22050851 DOI: 10.1016/B978-0-12-387718-5.00006-7 |
0.62 |
|
| 2011 |
Chan MK, Guest PC, Levin Y, Umrania Y, Schwarz E, Bahn S, Rahmoune H. Converging evidence of blood-based biomarkers for schizophrenia: an update. International Review of Neurobiology. 101: 95-144. PMID 22050850 DOI: 10.1016/B978-0-12-387718-5.00005-5 |
0.443 |
|
| 2011 |
Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Harris LW, Bahn S. Proteomic technologies for biomarker studies in psychiatry: advances and needs. International Review of Neurobiology. 101: 65-94. PMID 22050849 DOI: 10.1016/B978-0-12-387718-5.00004-3 |
0.565 |
|
| 2011 |
Stelzhammer V, Rothermundt M, Guest PC, Michael N, Sondermann C, Kluge W, Martins-de-Souza D, Rahmoune H, Bahn S. Proteomic changes induced by anaesthesia and muscle relaxant treatment prior to electroconvulsive therapy. Proteomics. Clinical Applications. 5: 644-9. PMID 22006837 DOI: 10.1002/Prca.201100040 |
0.537 |
|
| 2011 |
Bahn S, Schwarz E. [Serum-based biomarkers for psychiatric disorders]. Der Nervenarzt. 82: 1395-6, 1398, 1400 p. PMID 21909807 DOI: 10.1007/S00115-011-3346-Z |
0.43 |
|
| 2011 |
Kluge W, Alsaif M, Guest PC, Schwarz E, Bahn S. Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders. Expert Review of Molecular Diagnostics. 11: 721-33. PMID 21902534 DOI: 10.1586/Erm.11.61 |
0.447 |
|
| 2011 |
Koutroukides TA, Guest PC, Leweke FM, Bailey DM, Rahmoune H, Bahn S, Martins-de-Souza D. Characterization of the human serum depletome by label-free shotgun proteomics. Journal of Separation Science. 34: 1621-6. PMID 21644252 DOI: 10.1002/Jssc.201100060 |
0.569 |
|
| 2011 |
Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Wesseling H, Rahmoune H, Bahn S. The need for phosphoproteomic approaches in psychiatric research. Journal of Psychiatric Research. 45: 1404-6. PMID 21616503 DOI: 10.1016/J.Jpsychires.2011.04.007 |
0.524 |
|
| 2011 |
Martins-de-Souza D, Guest PC, Steeb H, Pietsch S, Rahmoune H, Harris LW, Bahn S. Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry. Proteomics. 11: 2347-53. PMID 21538886 DOI: 10.1002/Pmic.201000718 |
0.579 |
|
| 2011 |
Yang X, Levin Y, Rahmoune H, Ma D, Schöffmann S, Umrania Y, Guest PC, Bahn S. Comprehensive two-dimensional liquid chromatography mass spectrometric profiling of the rat hippocampal proteome. Proteomics. 11: 501-5. PMID 21268280 DOI: 10.1002/Pmic.201000525 |
0.322 |
|
| 2011 |
Krishnamurthy D, Levin Y, Harris LW, Umrania Y, Bahn S, Guest PC. Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry. Proteomics. 11: 495-500. PMID 21268279 DOI: 10.1002/Pmic.201000496 |
0.338 |
|
| 2011 |
Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, van Beveren NJ, Spain M, Barnes A, Steiner J, Rahmoune H, Bahn S. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology. 36: 1092-6. PMID 21251762 DOI: 10.1016/J.Psyneuen.2010.12.018 |
0.413 |
|
| 2011 |
Schwarz E, Whitfield P, Nahnsen S, Wang L, Major H, Leweke FM, Koethe D, Lio P, Bahn S. Alterations of primary fatty acid amides in serum of patients with severe mental illness. Frontiers in Bioscience (Elite Edition). 3: 308-14. PMID 21196311 |
0.307 |
|
| 2011 |
Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics. 11: 94-105. PMID 21182197 DOI: 10.1002/Pmic.201000291 |
0.403 |
|
| 2011 |
Chan MK, Tsang TM, Harris LW, Guest PC, Holmes E, Bahn S. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients. Molecular Psychiatry. 16: 1189-202. PMID 20921955 DOI: 10.1038/Mp.2010.100 |
0.406 |
|
| 2011 |
Martins-de-Souza D, Harris LW, Guest PC, Bahn S. The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxidants & Redox Signaling. 15: 2067-79. PMID 20673161 DOI: 10.1089/Ars.2010.3459 |
0.614 |
|
| 2011 |
Herberth M, Koethe D, Cheng TM, Krzyszton ND, Schoeffmann S, Guest PC, Rahmoune H, Harris LW, Kranaster L, Leweke FM, Bahn S. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Molecular Psychiatry. 16: 848-59. PMID 20585325 DOI: 10.1038/Mp.2010.71 |
0.444 |
|
| 2011 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Falkai P, Bahn S, Dias-Neto E, Turck CW. What Does Proteomics Tell Us About Schizophrenia Schizophrenia Bulletin. 37: 116-117. DOI: 10.1007/978-94-007-0837-2_16 |
0.777 |
|
| 2010 |
Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. Journal of Proteome Research. 9: 4476-89. PMID 20578731 DOI: 10.1021/Pr1002356 |
0.445 |
|
| 2010 |
Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Leweke FM, Rothermundt M, Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, ... ... Bahn S, et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomarker Insights. 5: 39-47. PMID 20520744 DOI: 10.4137/Bmi.S4877 |
0.413 |
|
| 2010 |
Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. Journal of Psychiatric Research. 44: 673-81. PMID 20100621 DOI: 10.1016/J.Jpsychires.2009.12.007 |
0.361 |
|
| 2010 |
Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren JM, Rothermundt M, McAllister G, Leweke FM, Steiner J, ... Bahn S, et al. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Molecular Psychiatry. 15: 118-9. PMID 20098438 DOI: 10.1038/Mp.2009.81 |
0.358 |
|
| 2010 |
Steiner J, Walter M, Guest P, Myint AM, Schiltz K, Panteli B, Brauner M, Bernstein HG, Gos T, Herberth M, Schroeter ML, Schwarz MJ, Westphal S, Bahn S, Bogerts B. Elevated S100B levels in schizophrenia are associated with insulin resistance. Molecular Psychiatry. 15: 3-4. PMID 20029405 DOI: 10.1038/Mp.2009.87 |
0.328 |
|
| 2010 |
Cheng TM, Lu YE, Guest PC, Rahmoune H, Harris LW, Wang L, Ma D, Stelzhammer V, Umrania Y, Wayland MT, Lió P, Bahn S. Identification of targeted analyte clusters for studies of schizophrenia. Molecular & Cellular Proteomics : McP. 9: 510-22. PMID 20007949 DOI: 10.1074/Mcp.M900372-Mcp200 |
0.458 |
|
| 2010 |
Martins-de-Souza D, Harris LW, Guest PC, Turck CW, Bahn S. The role of proteomics in depression research. European Archives of Psychiatry and Clinical Neuroscience. 260: 499-506. PMID 19997739 DOI: 10.1007/S00406-009-0093-2 |
0.66 |
|
| 2010 |
Wang L, Lockstone HE, Guest PC, Levin Y, Palotás A, Pietsch S, Schwarz E, Rahmoune H, Harris LW, Ma D, Bahn S. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. Journal of Proteome Research. 9: 521-7. PMID 19916557 DOI: 10.1021/Pr900867X |
0.459 |
|
| 2010 |
Levin Y, Jaros JA, Schwarz E, Bahn S. Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis. Journal of Proteomics. 73: 689-95. PMID 19896566 DOI: 10.1016/J.Jprot.2009.10.013 |
0.34 |
|
| 2010 |
Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Molecular Psychiatry. 15: 1088-100. PMID 19546861 DOI: 10.1038/Mp.2009.54 |
0.454 |
|
| 2010 |
Herberth M, Krzyszton DN, Koethe D, Craddock MR, Bulger E, Schwarz E, Guest P, Leweke FM, Bahn S. Differential effects on T-cell function following exposure to serum from schizophrenia smokers. Molecular Psychiatry. 15: 364-71. PMID 19002140 DOI: 10.1038/Mp.2008.120 |
0.345 |
|
| 2010 |
Krishnamurthy D, Guest PC, Harris L, Webster MJ, Bahn S. ANALYSIS OF THE HYPOTHALAMIC-PITUITARY ADRENAL AXIS IN PSYCHIATRIC DISORDERS Schizophrenia Research. 117: 492. DOI: 10.1097/01.Yic.0000405748.27693.0F |
0.307 |
|
| 2009 |
Ma D, Guest PC, Bahn S. Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis. Bioanalysis. 1: 1615-26. PMID 21083107 DOI: 10.4155/Bio.09.144 |
0.41 |
|
| 2009 |
Schwarz E, Leweke FM, Bahn S, Liò P. Clinical bioinformatics for complex disorders: a schizophrenia case study. Bmc Bioinformatics. 10: S6. PMID 19828082 DOI: 10.1186/1471-2105-10-S12-S6 |
0.383 |
|
| 2009 |
Kim WS, Wong J, Weickert CS, Webster MJ, Bahn S, Garner B. Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. Journal of Neurochemistry. 109: 1053-66. PMID 19519777 DOI: 10.1111/J.1471-4159.2009.06031.X |
0.327 |
|
| 2009 |
Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. Bmc Medical Genomics. 2: 28. PMID 19457239 DOI: 10.1186/1755-8794-2-28 |
0.386 |
|
| 2009 |
Weickert CS, Elashoff M, Richards AB, Sinclair D, Bahn S, Paabo S, Khaitovich P, Webster MJ. Transcriptome analysis of male-female differences in prefrontal cortical development. Molecular Psychiatry. 14: 558-61. PMID 19455171 DOI: 10.1038/Mp.2009.5 |
0.323 |
|
| 2009 |
Ma D, Chan MK, Lockstone HE, Pietsch SR, Jones DN, Cilia J, Hill MD, Robbins MJ, Benzel IM, Umrania Y, Guest PC, Levin Y, Maycox PR, Bahn S. Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex. Journal of Proteome Research. 8: 3284-97. PMID 19400588 DOI: 10.1021/Pr800983P |
0.415 |
|
| 2009 |
Somel M, Franz H, Yan Z, Lorenc A, Guo S, Giger T, Kelso J, Nickel B, Dannemann M, Bahn S, Webster MJ, Weickert CS, Lachmann M, Pääbo S, Khaitovich P. Transcriptional neoteny in the human brain. Proceedings of the National Academy of Sciences of the United States of America. 106: 5743-8. PMID 19307592 DOI: 10.1073/Pnas.0900544106 |
0.303 |
|
| 2009 |
Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Molecular Psychiatry. 14: 269-79. PMID 18256615 DOI: 10.1038/Sj.Mp.4002130 |
0.345 |
|
| 2008 |
Herberth M, Schwarz E, Bahn S. Problems and promise of immunological factors as biomarkers for schizophrenia. Biomarkers in Medicine. 2: 385-95. PMID 20477392 DOI: 10.2217/17520363.2.4.385 |
0.443 |
|
| 2008 |
Harris LW, Wayland M, Lan M, Ryan M, Giger T, Lockstone H, Wuethrich I, Mimmack M, Wang L, Kotter M, Craddock R, Bahn S. The cerebral microvasculature in schizophrenia: a laser capture microdissection study. Plos One. 3: e3964. PMID 19088852 DOI: 10.1371/Journal.Pone.0003964 |
0.431 |
|
| 2008 |
Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. Journal of Proteome Research. 7: 4266-77. PMID 18778095 DOI: 10.1021/Pr800188Y |
0.427 |
|
| 2008 |
Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ, Zhou J, Somel M, Harris LW, Holmes E, Pääbo S, Bahn S. Metabolic changes in schizophrenia and human brain evolution. Genome Biology. 9: R124. PMID 18681948 DOI: 10.1186/Gb-2008-9-8-R124 |
0.373 |
|
| 2008 |
Schwarz E, Bahn S. Biomarker discovery in psychiatric disorders. Electrophoresis. 29: 2884-90. PMID 18512679 DOI: 10.1002/Elps.200700710 |
0.457 |
|
| 2008 |
Schwarz E, Bahn S. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. Expert Review of Molecular Diagnostics. 8: 209-16. PMID 18366307 DOI: 10.1586/14737159.8.2.209 |
0.474 |
|
| 2008 |
Craddock RM, Huang JT, Jackson E, Harris N, Torrey EF, Herberth M, Bahn S. Increased alpha-defensins as a blood marker for schizophrenia susceptibility. Molecular & Cellular Proteomics : McP. 7: 1204-13. PMID 18349140 DOI: 10.1074/Mcp.M700459-Mcp200 |
0.426 |
|
| 2008 |
Schwarz E, Bahn S. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. British Journal of Pharmacology. 153: S133-6. PMID 18193070 DOI: 10.1038/Sj.Bjp.0707658 |
0.469 |
|
| 2008 |
Huang JT, Wang L, Prabakaran S, Wengenroth M, Lockstone HE, Koethe D, Gerth CW, Gross S, Schreiber D, Lilley K, Wayland M, Oxley D, Leweke FM, Bahn S. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Molecular Psychiatry. 13: 1118-28. PMID 17938634 DOI: 10.1038/Sj.Mp.4002108 |
0.45 |
|
| 2007 |
Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics. 90: 647-60. PMID 17950572 DOI: 10.1016/J.Ygeno.2007.08.005 |
0.304 |
|
| 2007 |
Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkötter J, Holmes E, Bahn S. CSF metabolic and proteomic profiles in patients prodromal for psychosis. Plos One. 2: e756. PMID 17712404 DOI: 10.1371/Journal.Pone.0000756 |
0.439 |
|
| 2007 |
Schwarz E, Levin Y, Wang L, Leweke FM, Bahn S. Peptide correlation: a means to identify high quality quantitative information in large-scale proteomic studies. Journal of Separation Science. 30: 2190-7. PMID 17683046 DOI: 10.1002/Jssc.200700190 |
0.339 |
|
| 2007 |
Levin Y, Schwarz E, Wang L, Leweke FM, Bahn S. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. Journal of Separation Science. 30: 2198-203. PMID 17668910 DOI: 10.1002/Jssc.200700189 |
0.36 |
|
| 2007 |
Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ, Bahn S. Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. Plos One. 2: e692. PMID 17668069 DOI: 10.1371/Journal.Pone.0000692 |
0.331 |
|
| 2007 |
Huang JT, McKenna T, Hughes C, Leweke FM, Schwarz E, Bahn S. CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects. Journal of Separation Science. 30: 214-25. PMID 17390615 DOI: 10.1002/Jssc.200600350 |
0.432 |
|
| 2007 |
Tkachev D, Mimmack ML, Huffaker SJ, Ryan M, Bahn S. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 557-63. PMID 17291371 DOI: 10.1017/S1461145706007334 |
0.401 |
|
| 2007 |
Prabakaran S, Wengenroth M, Lockstone HE, Lilley K, Leweke FM, Bahn S. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. Journal of Proteome Research. 6: 141-9. PMID 17203958 DOI: 10.1021/Pr060308A |
0.455 |
|
| 2007 |
Harris L, Swatton J, Wengenroth M, Wayland M, Lockstone H, Holland A, Faull R, Lilley K, Bahn S. Differences in Protein Profiles in Schizophrenia Prefrontal Cortex Compared to Other Major Brain Disorders Clinical Schizophrenia & Related Psychoses. 1: 73-91. DOI: 10.3371/Csrp.1.1.7 |
0.471 |
|
| 2006 |
Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. Plos Medicine. 3: e428. PMID 17090210 DOI: 10.1371/Journal.Pmed.0030428 |
0.475 |
|
| 2006 |
Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. Plos Medicine. 3: e327. PMID 16933966 DOI: 10.1371/Journal.Pmed.0030327 |
0.448 |
|
| 2006 |
Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Molecular Psychiatry. 11: 965-78. PMID 16894394 DOI: 10.1038/Sj.Mp.4001875 |
0.375 |
|
| 2006 |
Tsang TM, Huang JT, Holmes E, Bahn S. Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. Journal of Proteome Research. 5: 756-60. PMID 16602681 DOI: 10.1021/Pr0503782 |
0.41 |
|
| 2006 |
Bahn S, Leweke FM, Huang JT. Profiling of CSF: Author's Reply Plos Medicine. 3: e468. DOI: 10.1371/Journal.Pmed.0030468 |
0.451 |
|
| 2005 |
Franz H, Ullmann C, Becker A, Ryan M, Bahn S, Arendt T, Simon M, Pääbo S, Khaitovich P. Systematic analysis of gene expression in human brains before and after death. Genome Biology. 6: R112. PMID 16420671 DOI: 10.1186/Gb-2005-6-13-R112 |
0.301 |
|
| 2004 |
Swatton JE, Sellers LA, Faull RL, Holland A, Iritani S, Bahn S. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. The European Journal of Neuroscience. 19: 2711-9. PMID 15147305 DOI: 10.1111/J.0953-816X.2004.03365.X |
0.32 |
|
| 2004 |
Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, ... ... Bahn S, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry. 9: 684-97, 643. PMID 15098003 DOI: 10.1038/Sj.Mp.4001511 |
0.423 |
|
| 2004 |
Wilson KE, Ryan MM, Prime JE, Pashby DP, Orange PR, O'Beirne G, Whateley JG, Bahn S, Morris CM. Functional genomics and proteomics: application in neurosciences. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 529-38. PMID 15026490 DOI: 10.1136/Jnnp.2003.026260 |
0.321 |
|
| 2004 |
Mimmack ML, Brooking J, Bahn S. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biological Psychiatry. 55: 337-45. PMID 14960285 DOI: 10.1016/J.Biopsych.2003.09.007 |
0.313 |
|
| 2004 |
Ryan MM, Huffaker SJ, Webster MJ, Wayland M, Freeman T, Bahn S. Application and optimization of microarray technologies for human postmortem brain studies. Biological Psychiatry. 55: 329-36. PMID 14960284 DOI: 10.1016/J.Biopsych.2003.10.016 |
0.338 |
|
| 2004 |
Swatton JE, Prabakaran S, Karp NA, Lilley KS, Bahn S. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Molecular Psychiatry. 9: 128-43. PMID 14708031 DOI: 10.1038/Sj.Mp.4001475 |
0.326 |
|
| 2003 |
Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362: 798-805. PMID 13678875 DOI: 10.1016/S0140-6736(03)14289-4 |
0.447 |
|
| 2002 |
Bahn S. Gene expression in bipolar disorder and schizophrenia: new approaches to old problems. Bipolar Disorders. 4: 70-2. PMID 12479683 DOI: 10.1034/J.1399-5618.4.S1.28.X |
0.402 |
|
| 2002 |
Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proceedings of the National Academy of Sciences of the United States of America. 99: 4680-5. PMID 11930015 DOI: 10.1073/Pnas.032069099 |
0.412 |
|
| 2001 |
Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. Gene expression profiling in the post-mortem human brain--no cause for dismay. Journal of Chemical Neuroanatomy. 22: 79-94. PMID 11470556 DOI: 10.1016/S0891-0618(01)00099-0 |
0.373 |
|
| 2001 |
Ryan M, Starkey M, Faull R, Emson P, Bahn S. Indexing-based differential display--studies on post-mortem Alzheimer's brains. Brain Research. Molecular Brain Research. 88: 199-202. PMID 11295249 DOI: 10.1016/S0169-328X(01)00007-9 |
0.313 |
|
| 1999 |
Bahn S, Wisden W, Dunnett SB, Svendsen C. The intrinsic specification of gamma-aminobutyric acid type A receptor alpha6 subunit gene expression in cerebellar granule cells. The European Journal of Neuroscience. 11: 2194-8. PMID 10336690 DOI: 10.1046/J.1460-9568.1999.00662.X |
0.547 |
|
| 1997 |
Bahn S, Jones A, Wisden W. Directing gene expression to cerebellar granule cells using gamma-aminobutyric acid type A receptor alpha6 subunit transgenes. Proceedings of the National Academy of Sciences of the United States of America. 94: 9417-21. PMID 9256497 DOI: 10.1073/Pnas.94.17.9417 |
0.549 |
|
| 1997 |
Jones A, Korpi ER, McKernan RM, Pelz R, Nusser Z, Mäkelä R, Mellor JR, Pollard S, Bahn S, Stephenson FA, Randall AD, Sieghart W, Somogyi P, Smith AJ, Wisden W. Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1350-62. PMID 9006978 DOI: 10.1523/Jneurosci.17-04-01350.1997 |
0.531 |
|
| 1997 |
Jones A, Korpi ER, McKernan RM, Pelz R, Nusser Z, Mäkelä R, Mellor JR, Pollard S, Bahn S, Stephenson FA, Randall AD, Sieghart W, Somogyi P, Smith AJH, Wisden W. Ligand-Gated Ion Channel Subunit Partnerships: GABAAReceptor α6Subunit Gene Inactivation Inhibits δ Subunit Expression The Journal of Neuroscience. 17: 1350-1362. DOI: 10.1523/JNEUROSCI.17-04-01350.1997 |
0.462 |
|
| 1996 |
Wisden W, Korpi ER, Bahn S. The cerebellum: a model system for studying GABAA receptor diversity. Neuropharmacology. 35: 1139-60. PMID 9014130 DOI: 10.1016/S0028-3908(96)00076-7 |
0.533 |
|
| 1996 |
Bahn S, Harvey RJ, Darlison MG, Wisden W. Conservation of gamma-aminobutyric acid type A receptor alpha 6 subunit gene expression in cerebellar granule cells. Journal of Neurochemistry. 66: 1810-8. PMID 8780005 DOI: 10.1046/J.1471-4159.1996.66051810.X |
0.537 |
|
| 1996 |
Jones A, Bahn S, Grant AL, Köhler M, Wisden W. Characterization of a cerebellar granule cell-specific gene encoding the gamma-aminobutyric acid type A receptor alpha 6 subunit. Journal of Neurochemistry. 67: 907-16. PMID 8752095 DOI: 10.1046/J.1471-4159.1996.67030907.X |
0.551 |
|
| 1994 |
Bahn S, Volk B, Wisden W. Kainate receptor gene expression in the developing rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 5525-47. PMID 8083752 DOI: 10.1523/Jneurosci.14-09-05525.1994 |
0.557 |
|
| 1994 |
Bahn S, Volk B, Wisden W. Kainate receptor gene expression in the developing rat brain The Journal of Neuroscience. 14: 5525-5547. DOI: 10.1523/JNEUROSCI.14-09-05525.1994 |
0.492 |
|
| Show low-probability matches. |